Alex Azar, refusing to acknowledge election results, says they're not working with Biden team on vaccine rollout

With data now out on two experimental vaccines, the course of the raging US outbreak and the success of the federal government’s $18 billion vaccine acceleration program hinges in part on whether officials can successfully roll doses out to the general public, should they receive FDA authorization.

It’s a delicate and highly technical process, one that officials have been game-planning in military tabletop style for months. But so far neither those officials nor other representatives from the federal government have spoken to the administration that will take over just a month into the likely rollout, HHS secretary Alex Azar said Wednesday.